Edesa Biotech (EDSA) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Edesa Biotech, a clinical-stage biopharmaceutical company, is set to participate in multiple international conferences, highlighting its focus on developing treatments for inflammatory and immune-related diseases. The company is advancing several drug candidates, including therapies for vitiligo, allergic contact dermatitis, and acute respiratory distress syndrome.
For further insights into EDSA stock, check out TipRanks’ Stock Analysis page.